These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

200 related items for PubMed ID: 9926976

  • 1. Must we really fear toxicity of conventional amphotericin B in oncological patients?
    Mayer J, Doubek M, Vorlìcek J.
    Support Care Cancer; 1999 Jan; 7(1):51-5. PubMed ID: 9926976
    [Abstract] [Full Text] [Related]

  • 2. Reduced nephrotoxicity of conventional amphotericin B therapy after minimal nephroprotective measures: animal experiments and clinical study.
    Mayer J, Doubek M, Doubek J, Horký D, Scheer P, Stepánek M.
    J Infect Dis; 2002 Aug 01; 186(3):379-88. PubMed ID: 12134234
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Effects of hydration with salt repletion on renal toxicity of conventional amphotericin B empirical therapy: a prospective study in patients with hematological malignancies.
    Girmenia C, Cimino G, Di Cristofano F, Micozzi A, Gentile G, Martino P.
    Support Care Cancer; 2005 Dec 01; 13(12):987-92. PubMed ID: 15756584
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Potassium depletion potentiates amphotericin-B-induced toxicity to renal tubules.
    Bernardo JF, Murakami S, Branch RA, Sabra R.
    Nephron; 1995 Dec 01; 70(2):235-41. PubMed ID: 7566310
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. [Safety of long-term administration of conventional amphotericin B in oncology patients].
    Doubek M, Mayer J, Horký D.
    Cas Lek Cesk; 2002 Mar 01; 141(5):156-9. PubMed ID: 11998223
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Spironolactone: is it a novel drug for the prevention of amphotericin B-related hypokalemia in cancer patients?
    Ural AU, Avcu F, Cetin T, Beyan C, Kaptan K, Nazaroglu NK, Yalcin A.
    Eur J Clin Pharmacol; 2002 Jan 01; 57(11):771-3. PubMed ID: 11868798
    [Abstract] [Full Text] [Related]

  • 16. Are salt loading and prolonging infusion period effective in prevention of amphotericin B-induced nephrotoxicity?
    Karimzadeh I, Farsaei S, Khalili H, Dashti-Khavidaki S.
    Expert Opin Drug Saf; 2012 Nov 01; 11(6):969-83. PubMed ID: 22950480
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. [Retrospective investigation on the cases treated with liposomal amphotericin B].
    Yamagishi Y, Mikamo H.
    Jpn J Antibiot; 2010 Oct 01; 63(5):347-64. PubMed ID: 21268407
    [Abstract] [Full Text] [Related]

  • 20. Low-dose amphotericin B lipid complex vs. conventional amphotericin B for empirical antifungal therapy of neutropenic fever in patients with hematologic malignancies--a randomized, controlled trial.
    Subirà M, Martino R, Gómez L, Martí JM, Estany C, Sierra J.
    Eur J Haematol; 2004 May 01; 72(5):342-7. PubMed ID: 15059069
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.